Skip to main content
FBLG
NASDAQ Life Sciences

FibroBiologics Doses First Patients in Phase 1/2 Trial for Diabetic Foot Ulcers

Reported by Reuters
Sentiment info
Positive
Importance info
7
Price
$1.08
Mkt Cap
$5.469M
52W Low
$0.952
52W High
$19.8
Market data snapshot near publication time

Summary

FibroBiologics has dosed the first patients in its Phase 1/2 clinical trial for Cywc628, a treatment for diabetic foot ulcers. This marks a positive step in the company's pipeline development, providing a much-needed R&D update amidst its severe financial distress. The company recently issued a going concern warning and is actively diluting shareholders through ATM offerings to fund operations.

At the time of this announcement, FBLG was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $0.95 to $19.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FBLG - Latest Insights

FBLG
Jun 03, 2026, 7:26 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.08
Real-time Price: $0.900 info
Change: -$0.180 (-17%) info
Market Cap: $4.849M info
FBLG
May 05, 2026, 5:39 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.31
Real-time Price: $0.900 info
Change: -$0.410 (-31%) info
Market Cap: $4.849M info
FBLG
May 05, 2026, 7:21 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.48
Real-time Price: $0.900 info
Change: -$0.580 (-39%) info
Market Cap: $4.849M info
FBLG
May 05, 2026, 7:18 AM EDT
Filing Type: DEFA14A
Importance Score:
9
Price at Filing: $1.48
Real-time Price: $0.900 info
Change: -$0.580 (-39%) info
Market Cap: $4.849M info
FBLG
May 05, 2026, 7:18 AM EDT
Filing Type: DEF 14A
Importance Score:
9
Price at Filing: $1.48
Real-time Price: $0.900 info
Change: -$0.580 (-39%) info
Market Cap: $4.849M info
FBLG
May 04, 2026, 8:33 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.42
Real-time Price: $0.900 info
Change: -$0.520 (-37%) info
Market Cap: $4.849M info
FBLG
May 01, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $1.46
Real-time Price: $0.900 info
Change: -$0.560 (-38%) info
Market Cap: $4.849M info
FBLG
Apr 30, 2026, 5:55 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.35
Real-time Price: $0.900 info
Change: -$0.4464 (-33%) info
Market Cap: $4.849M info
FBLG
Apr 30, 2026, 5:21 PM EDT
Source: Wiseek News
Importance Score:
9
Price at Filing: $1.34
Real-time Price: $0.900 info
Change: -$0.440 (-33%) info
Market Cap: $4.849M info
FBLG
Apr 30, 2026, 5:19 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.35
Real-time Price: $0.900 info
Change: -$0.4464 (-33%) info
Market Cap: $4.849M info